Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data

Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data

Human papillomavirus (HPV) infection is the recognized cause of almost all cervical cancers. Despite the reduction in incidence due to a wide use of screening programs and a specific vaccine, the prognosis of cervical cancer remains poor, especially for late-stage and relapsed disease. Considering t...

Full description

Bibliographic Details
Main Authors: Simona Duranti, Antonella Pietragalla, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Giovanni Scambia, Domenica Lorusso
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
cervical cancer
immunotherapy
immune checkpoint inhibitors
PD-1
PD-L1
CTLA4
Online Access:https://www.mdpi.com/2072-6694/13/9/2089

Internet

https://www.mdpi.com/2072-6694/13/9/2089

Similar Items